Orion Pharma Limited IPO Result DSE Dhaka Stock Exchange http://www.dsebd.org.

Orion Pharma Limited IPO Result DSE Dhaka Stock Exchange http://www.dsebd.org.

Subscription Open Date: 06.01.2013
Subscription Close Date: 10.01.2013 )
IPO Result Date: 



IPO Information: 
Orion Pharma Limited
Nature of Business: The Company owns and operates a modern pharmaceuticals factory and produces and sells pharmaceuticals drugs and medicine.

Major Product: Enliven (Imatinib Mesylate) capsule, Betacal (Atenolol plus amlodipine) tab, Vertex injection (Ceftriaxone sodium), Clognil plus (Clopidogrel+ Aspirin) tab, Pep (Zinc sulphate) Tab/Syrup, Deslor (Desloratadine) Tab/Syp, Axet (Cefuroxime) Tab/inj, Pedicef (Cefpodoxime) susp, Azalid (Azithromycin) Tab/Sus,Truso (Cefixime) Cap/sus.

Subscription Open January 06, 2013
Subscription Close January 10, 2013
Subscription period for NRB January 06, 2013 to January 19, 2013.Authorized Capital Tk. 5,000,000,000
Pre- IPO paid-up Capital Tk. 1,550,000,000. IPO size in shares 40,000,000. IPO size in Tk. at face value Tk. 400,000,000 IPO size in Tk.

Offer Price
Tk. 2,400,000,000 (including premium of Tk. 2,000,000,000).Post IPO Paid-up Capital Tk. 1,950,000,000. Face Value per share Tk. 10.00. Offer Price per share Tk. 60.00 (including a premium of Tk. 50.00 per share). Market Lot (Shares) 100. Use of IPO Proceeds For construction of expansion project of Orion Pharma Limited at Valuka, Mymensingh in terms of the expansion of the existing product line along with the addition of new product lines. NAV per share Tk. 76.87 (considering revaluation reserve) as on December 31, 2011. Tk. 61.43 (without revaluation reserve) as on December 31, 2011.EPS Tk. 5.57 for the year ended December 31, 2011.Issue Manager ICB Capital Management Limited Auditors S. F. Ahmed & Co. Website www.orion-group.net

No comments:

Post a Comment